Revelation Biosciences In...

NASDAQ: REVB · Real-Time Price · USD
2.57
-0.01 (-0.39%)
At close: Aug 15, 2025, 3:51 PM
2.60
1.33%
After-hours: Aug 15, 2025, 07:36 PM EDT

Revelation Biosciences Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-18.74M -23.39M -24.02M -24.5M -15.9M -8.96M -120.25K 875.06K 2.33M 1.95M -10.83M -13.48M -15.36M -15.99M -11.99M -11.02M -8.14M -5.67M
Depreciation & Amortization
49.59K 42.36K 41.41K 40.45K 26.01K 25.05K 25.05K 25.05K 25.05K 25.05K 25.05K 25.05K 24.86K 22.4K 16.78K 10.52K 4.45K 642.00
Stock-Based Compensation
591.63K 424.4K 233.04K 217.57K 153.38K 155.72K 155.72K 155.99K 164.57K 195.32K 301.12K 374.67K 465.31K 506.44K 470.88K 408.81K 277.49K 146.17K
Other Working Capital
-3.35M 2.59M 2.96M 2.92M 6.63M -19.18K 232.47K 182.58K -597.19K -1.63M -64.93K 1.07M 1.76M 2.1M 625.86K -319.53K -918.59K 178.35K
Other Non-Cash Items
4.1M 3.03M 3.12M 3.04M -154.57K -573.57K -8.25M -8.91M -8.38M -7.31M 449.62K 1.18M 691.03K 58.01K 52.38K 1.15M 1.24M 1.22M
Deferred Income Tax
n/a n/a n/a -15.89K -78.86K -78.86K -78.86K 653.05K 212.42K -434.66K -434.66K -1.15M -647.08K n/a n/a n/a n/a n/a
Change in Working Capital
-3.72M 1.62M 2.31M 4.64M 6.92M 883.44K 982.13K 973.72K -599.8K -2.39M -730.97K -97.81K 1.17M 1.87M 356.22K -154.33K -877.44K 397.11K
Operating Cash Flow
-17.72M -18.28M -18.32M -16.58M -9.04M -8.55M -7.29M -6.23M -6.25M -7.96M -11.22M -13.15M -13.65M -13.54M -11.09M -9.6M -7.5M -3.91M
Capital Expenditures
3.00 -19.17K -38.34K -56.03K -38.34K -19.17K n/a n/a n/a n/a n/a 16.15K 16.15K -32.86K -131.96K -148.12K -148.12K -99.1K
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -74.04M -74.04M -74.04M
Sales Maturities Of Investments
-281.97K -281.97K -281.97K -281.97K -281.97K n/a n/a n/a n/a n/a n/a n/a 281.97K 281.97K 281.97K 281.97K n/a n/a
Other Investing Acitivies
n/a 301.14K 301.14K 301.14K 301.14K n/a n/a n/a n/a n/a n/a n/a -281.97K -281.97K -281.97K -281.97K n/a n/a
Investing Cash Flow
-281.97K 1.00 -19.17K -36.86K -19.17K -19.17K n/a n/a n/a n/a n/a 16.15K 16.15K -32.86K -131.96K -74.19M -74.19M -74.14M
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -796.88K -796.88K -796.88K -796.88K n/a -275K -275K -275K
Common Stock Repurchased
n/a n/a n/a 5K 5K 5K n/a -5K -5K -5K -7.65M -33.35M -33.35M -33.35M -25.7M n/a n/a n/a
Dividend Paid
-3.18M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
6.57M n/a 127.00 127.00 127.00 127.00 19.00 19.00 19.00 7.26M 11.54M 12.31M 12.31M 5.05M 774.35K -3.15M -2.15M -2.15M
Financial Cash Flow
10.82M 7.43M 12.85M 9.16M 5.42M 5.42M 14.03M 14.03M 18.48M 18.48M 15.2M -9.73M -14.18M -14.18M -16.92M 78.94M 79.94M 79.94M
Net Cash Flow
-6.9M -10.85M -5.49M -7.45M -3.64M -3.15M 6.74M 7.8M 12.24M 10.52M 3.98M 2.06M -2.9M -2.83M -3.22M 6.12M 9.23M 12.87M
Free Cash Flow
-25.21M -23.28M -23.34M -21.61M -9.07M -8.57M -7.29M -6.23M -6.25M -7.96M -11.22M -13.13M -13.64M -13.57M -11.22M -9.75M -7.65M -4M